Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling

Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy

(2009) N. T. Ihle et al.   MOLECULAR CANCER THERAPEUTICS

The Role of Targeting Mammalian Target of Rapamycin in Lung Cancer

(2008) Sumanta Kumar Pal et al.   Clinical Lung Cancer

Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells

(2008) Monica Banez-Coronel et al.   CURRENT CANCER DRUG TARGETS

Cotargeting survival signaling pathways in cancer

(2008) Steven Grant   JOURNAL OF CLINICAL INVESTIGATION

Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin

(2008) A. Toschi et al.   MOLECULAR AND CELLULAR BIOLOGY

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

(2008) Scott M. Wilhelm et al.   MOLECULAR CANCER THERAPEUTICS

PI3K pathway alterations in cancer: variations on a theme

(2008) T L Yuan et al.   ONCOGENE